Related references
Note: Only part of the references are listed.Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease
Qian Wang et al.
KIDNEY INTERNATIONAL (2018)
Therapeutic Targets in Polycystic Liver Disease
Tatyana V. Masyuk et al.
CURRENT DRUG TARGETS (2017)
Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression
Andrew J. Streets et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease
Cibele S. Pinto et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
PDE4D phosphorylation: A coincidence detector integrating multiple signaling pathways
Delphine Mika et al.
CELLULAR SIGNALLING (2016)
The Popeye domain containing protein family - A novel class of cAMP effectors with important functions in multiple tissues
Roland F. R. Schindler et al.
PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY (2016)
Dimerization of CAMP phosphodiesterase-4 (PDE4) in living cells requires interfaces located in both the UCR1 and catalytic unit domains
Graeme B. Bolger et al.
CELLULAR SIGNALLING (2015)
UCR1C is a novel activator of phosphodiesterase 4 (PDE4) long isoforms and attenuates cardiomyocyte hypertrophy
Li Wang et al.
CELLULAR SIGNALLING (2015)
A polycystin-centric view of cyst formation and disease: the polycystins revisited
Albert C. M. Ong et al.
KIDNEY INTERNATIONAL (2015)
Autosomal dominant polycystic kidney disease: the changing face of clinical management
Albert C. M. Ong et al.
LANCET (2015)
Vasopressin and disruption of calcium signalling in polycystic kidney disease
Fouad T. Chebib et al.
NATURE REVIEWS NEPHROLOGY (2015)
Engineered stabilization and structural analysis of the autoinhibited conformation of PDE4
Peder Cedervall et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The future of EPAC-targeted therapies: agonism versus antagonism
Euan Parnell et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Cystic Fibrosis Transmembrane Conductance Regulator Activation by Roflumilast Contributes to Therapeutic Benefit in Chronic Bronchitis
James A. Lambert et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2014)
The upstream conserved regions (UCRs) mediate homo- and hetero-oligomerization of type 4 cyclic nucleotide phosphodiesterases (PDE4s)
Moses Xie et al.
BIOCHEMICAL JOURNAL (2014)
The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma membrane of VCaP prostate cancer cells
D. J. P. Henderson et al.
BRITISH JOURNAL OF CANCER (2014)
Epac and the high affinity rolipram binding conformer of PDE4 modulate neurite outgrowth and myelination using an in vitro spinal cord injury model
S. D. Boomkamp et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Anchored PDE4 regulates chloride conductance in wild-type and ΔF508-CFTR human airway epithelia
Elise Blanchard et al.
FASEB JOURNAL (2014)
Strategies Targeting cAMP Signaling in the Treatment of Polycystic Kidney Disease
Vicente E. Torres et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Adenylyl Cyclase 6 Deficiency Ameliorates Polycystic Kidney Disease
Sara Rees et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Advances in targeting cyclic nucleotide phosphodiesterases
Donald H. Maurice et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
A Rapid Membrane Potential Assay to Monitor CFTR Function and Inhibition
Rangan Maitra et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
Exchange Protein Directly Activated by cAMP (epac): A Multidomain cAMP Mediator in the Regulation of Diverse Biological Functions
Martina Schmidt et al.
PHARMACOLOGICAL REVIEWS (2013)
Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation
Kirsty F. MacKenzie et al.
BIOCHEMICAL JOURNAL (2011)
Cyclic AMP-mediated cyst expansion
Darren P. Wallace
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease
Sara Terryn et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Elucidation of a Structural Basis for the Inhibitor-Driven, p62 (SQSTM1)-Dependent Intracellular Redistribution of cAMP Phosphodiesterase-4A4 (PDE4A4)
Jonathan P. Day et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Formation of cysts by principal-like MDCK cells depends on the synergy of cAMP- and ATP-mediated fluid secretion
Bjoern Buchholz et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2011)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases
Yun-Hee Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cyclic Nucleotide Phosphodiesterases (PDE) and Peptide Motifs
Therese Keravis et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
Alex B. Burgin et al.
NATURE BIOTECHNOLOGY (2010)
Putting the lid on phosphodiesterase 4
Miles D. Houslay et al.
NATURE BIOTECHNOLOGY (2010)
Underpinning compartmentalised cAMP signalling through targeted cAMP breakdown
Miles D. Houslay
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease
Baoxue Yang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Dynamic regulation, desensitization, and cross-talk in discrete subcellular microdomains during β2-adrenoceptor and prostanoid receptor cAMP signaling
Debbie Willoughby et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system
E. Parker et al.
KIDNEY INTERNATIONAL (2007)
cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system - A molecular toolbox for generating compartmentalized cAMP signaling
Miles D. Houslay et al.
CIRCULATION RESEARCH (2007)
Antidepressant-like effects of PDE4 inhibitors mediated by the high-affinity rolipram binding state (HARBS) of the phosphodiesterase-4 enzyme (PDE4) in rats
HT Zhang et al.
PSYCHOPHARMACOLOGY (2006)
Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies
A Lerner et al.
BIOCHEMICAL JOURNAL (2006)
Phosphodiesterase-4 as a therapeutic target
MD Houslay et al.
DRUG DISCOVERY TODAY (2005)
RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with βarrestin to control the protein kinase A/AKAP79-mediated switching of the β2-adrenergic receptor to activation of ERK in HEK293B2 cells
MJ Lynch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The oligomerization state determines regulatory properties and inhibitor sensitivity of type 4 cAMP-specific phosphodiesterases
W Richter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The relationship between cell proliferation, Cl- secretion, and renal cyst growth:: A study using CFTR inhibitors
HY Li et al.
KIDNEY INTERNATIONAL (2004)
Localized effects of cAMP mediated by distinct routes of protein kinase A
K Tasken et al.
PHYSIOLOGICAL REVIEWS (2004)
Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling
M Conti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization
MD Houslay et al.
BIOCHEMICAL JOURNAL (2003)
Dimerization of the type 4 cAMP-specific phosphodiesterases is mediated by the upstream conserved regions (UCRs)
W Richter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Crystal structure of phosphodiesterase 4D and inhibitor complex
ME Lee et al.
FEBS LETTERS (2002)
Cyclic AMP-dependent transcriptional up-regulation of phosphodiesterase 4D5 in human airway smooth muscle cells -: Identification and characterization of a novel PDE4D5 promoter
IR Le Jeune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Long PDE4 cAMP specific phosphodiesterases are activated by protein kinase A-mediated phosphorylation of a single serine residue in Upstream Conserved Region 1 (UCR1)
SJ MacKenzie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons
C D'Sa et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Phorbol 12-myristate 13-acetate triggers the protein kinase A-mediated phosphorylation and activation of the PDE4D5 cAMP phosphodiesterase in human aortic smooth muscle cells through a route involving extracellular signal regulated kinase (ERK)
G Baillie et al.
MOLECULAR PHARMACOLOGY (2001)
Sub-family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP-specific phosphodiesterases
GS Baillie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Short term feedback regulation of cAMP in FRTL-5 thyroid cells - Role of PDE4D3 phosphodiesterase activation
N Oki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
UCR1 and UCR2 domains unique to the cAMP-specific phosphodiesterase family form a discrete module via electrostatic interactions
MB Beard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
